Risperidone-Induced Neuroleptic Malignant Syndrome in Neurodegenerative Disease: A Case Report

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Neuroleptic malignant syndrome (NMS) is uncommon with the use of atypical antipsychotics.<sup>1</sup> This report describes the case of a 34-year-old male with suspected neurodegenerative disease who developed this complication with the use of risperidone. He was successfully treated with dantrolene and bromocriptine and was discharged in stable condition after 7 days.

Prim Care Companion J Clin Psychiatry 2007;9(3):237-238 [letter]

https://doi.org/10.4088/PCC.v09n0311f